

Author: Spurrell Emma L.
Publisher: Informa Healthcare
ISSN: 1369-1643
Source: Sarcoma, Vol.8, Iss.4, 2004-12, pp. : 113-121
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Purpose: To discuss a case of ovarian fibromatosis/massive ovarian oedema, intra-abdominal fibromatosis, sclerosing peritonitis and Meig's syndrome. To review the reported therapeutic options. Patients: Case report of a 27-year-old female with the combined pathology of ovarian fibromatosis/massive ovarian oedema, intra-abdominal fibromatosis, sclerosing peritonitis and Meig's syndrome. Methods: This patient was treated with supportive care and cytotoxic chemotherapy. Results: Despite the benign nature of the ovarian pathology, this patient presented with life-threatening complications. Response to treatment was probably multi-factorial combining the effects of cytotoxics, use of steroids and good supportive care. She remains in complete remission 4 years post completion of chemotherapy. Conclusion: There are reports in the literature of ovarian fibromatosis/massive ovarian oedema, luteinised thecomas, intra-abdominal fibromatosis and Meig's syndrome occurring together in a variety of combinations. Treatment has been described with radiotherapy, cytotoxic and non-cytotoxic chemotherapy regimens. This case provides a link between ovarian fibromatosis/massive ovarian oedema, intra-abdominal fibromatosis, sclerosing peritonitis and Meig's syndrome not previously described.
Related content


By Munkarah A. Levenback C. Wolf J.K. Bodurka-Bevers D. Tortolero-Luna G. Morris R.T. Gershenson D.M.
Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. :


Palliative Sclerosis of Intra-abdominal Cystic Ovarian or Peritoneal Carcinoma
Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. :






By Wcislo Gabriel Szarlej-Wcislo Katarzyna Szczylik Cezary
Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 8, 2007-08 ,pp. :